Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

570

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Type 2 Diabetes
Interventions
DRUG

Saxagliptin

Oral tablet, once daily for 24 weeks

DRUG

Placebo

oral tablet, once daily for 24 weeks

DRUG

Metformin

oral tablet, once daily for 24 weeks

Trial Locations (30)

Unknown

Research Site, Hefei

Research Site, Beijing

Research Site, Chongqing

Research Site, Guangzhou

Research Site, Shijiazhuang

Research Site, Ha'er Bing

Research Site, Wuhan

Research Site, Changsha

Research Site, Nanjing

Research Site, Changchun

Research Site, Dalian

Research Site, Shenyang

Research Site, Shanghai

Research Site, Chengdu

Research Site, Hangzhou

Research Site, Tianjin

Research Site, Hyderabad

Research Site, Bangalore

Research Site, Mangalore

Research Site, Nagpur

Research Site, Bangalore

Research Site, Seongnam-si

Research Site, Bucheon-si

Research Site, Daegu

Research Site, Goyang

Research Site, Gwangju

Research Site, Incheon

Research Site, Pusan

Research Site, Seoul

Research Site, Uijeongbu-si

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY